ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1026

Patients’ Barriers to Total Joint Arthroplasty: Associations with the Orthopedic Consultation

Insa Mannstadt1, J. Alex Gibbons2, Troy Amen1, Mangala Rajan3, Sarah Young4, Michael Parks1, Mark Figgie1, Anne Bass5, Linda Russell1, Bella Mehta5, iris Navarro-Millán1 and Susan Goodman1, 1Hospital for Special Surgery, New York, NY, 2Columbia University Vagelos College of Physicians & Surgeons, New York, NY, 3Weill Cornell Medicine, New York, NY, 4Binghamton University, Binghamton, NY, 5Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

Meeting: ACR Convergence 2023

Keywords: Access to care, Arthroplasty, Disparities, Qualitative Research, Surveys

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1013–1032) Healthcare Disparities in Rheumatology Poster II: Socioeconomic Determinants

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: While racial/ethnic disparities in total joint arthroplasty (TJA) utilization are well-documented, the impact of orthopedic specialists on patients’ perceptions of TJA is poorly understood. We aimed to assess the relationship between orthopedic consultation and patients’ perspectives on TJA barriers.

Methods: This multi-institutional prospective cohort study was conducted from 2/2020 to 7/2022. We surveyed patients at 2 large urban academic institutions (Hospital for Special Surgery; New York Presbyterian-Brooklyn Methodist Hospital) and 2 national arthritis cohorts (ArthritisPower; CreakyJoints Español). The electronic questionnaire was developed through thematic analysis of semi-structured interviews conducted with minority patients experiencing advanced osteoarthritis. The questionnaire assessed participants’ barriers to TJA were using a 5-level Likert scale. Responses were categorized through a top-2 box analysis: “Highly important” (very or extremely important) and “Not as important” (bottom 3 levels). We evaluated differences in characteristics between those who had and those who had not consulted an orthopedist. Multiple logistic regression models were used to analyze the adjusted odds ratios (aOR) of orthopedic consultation on patients’ ratings of barriers to TJA. Models controlled for patient factors, including race, age, HOOS, JR/KOOS, JR, insurance, education, and prior discussion of TJA with any doctor.

Results: 696 participants who completed the survey were included in the analysis (94% of respondents; 24% of total queried). Most were female (88%), average age 59.3 years, 77% White participants, 11% Black, and 9% Hispanic. 49% reported having had an orthopedic consultation. The questionnaire examined five TJA barriers: 1. Trust in surgeon, including factors like finding a qualified surgeon; 2. Cost/insurance, such as challenges related to co-pays and insurance coverage; 3. Recovery concerns, such as insufficient social support; 4. Surgical outcome, such as the potential need for additional TJA due to young age; and 5. Timing of surgery, whereby other health concerns take precedence over TJA. Participants who had consulted with an orthopedist were older (p< 0.05), more likely to be college graduates (p< 0.01), Medicare beneficiaries (p< 0.05), have consulted with a primary care physician (p< 0.01), and have attempted arthritis treatments, such as joint injections (p< 0.01), braces (p< 0.01), and physical therapy (p< 0.01) (Table 1). After adjusting for patient factors, orthopedic consultation was a significant predictor of lower barriers relating to cost/insurance (aOR (95% CI): 0.52 (0.36, 0.76)) and timing of surgery (aOR (95% CI): 0.49 (0.31, 0.79)). (Table 2) Patient factors, including race and insurance, did not have significant interaction with orthopedic consultation (all p >0.05).

Conclusion: While those with an orthopedic consultation were able to overcome cost/insurance and timing barriers to consider TJA, significant barriers persisted. Developing strategies to identify and address the TJA barriers among minority groups may help increase utilization within these groups.

Supporting image 1

Supporting image 2


Disclosures: I. Mannstadt: None; J. Gibbons: None; T. Amen: None; M. Rajan: None; S. Young: None; M. Parks: None; M. Figgie: hs2, 8, joint effort aso, 8, lima, 2, 9, wishbone medical, 2, 4, 8, 9, 10; A. Bass: None; L. Russell: None; B. Mehta: Janssen, 1, Novartis, 5; i. Navarro-Millán: None; S. Goodman: NIH, 5, Novartis, 5.

To cite this abstract in AMA style:

Mannstadt I, Gibbons J, Amen T, Rajan M, Young S, Parks M, Figgie M, Bass A, Russell L, Mehta B, Navarro-Millán i, Goodman S. Patients’ Barriers to Total Joint Arthroplasty: Associations with the Orthopedic Consultation [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/patients-barriers-to-total-joint-arthroplasty-associations-with-the-orthopedic-consultation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patients-barriers-to-total-joint-arthroplasty-associations-with-the-orthopedic-consultation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology